These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


362 related items for PubMed ID: 204498

  • 1. The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.
    Simantov R, Childers SR, Snyder SH.
    Eur J Pharmacol; 1978 Feb 01; 47(3):319-31. PubMed ID: 204498
    [Abstract] [Full Text] [Related]

  • 2. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL, Pasternak GW.
    Proc Natl Acad Sci U S A; 1981 Oct 01; 78(10):6181-5. PubMed ID: 6273857
    [Abstract] [Full Text] [Related]

  • 3. Development of methionine-enkephalin and naloxone binding sites in regions of rat brain.
    Tsang D, Ng SC, Ho KP.
    Brain Res; 1982 Apr 01; 255(4):637-44. PubMed ID: 6280806
    [Abstract] [Full Text] [Related]

  • 4. Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the ginea pig.
    Leslie FM, Kosterlitz HW.
    Eur J Pharmacol; 1979 Jul 01; 56(4):379-83. PubMed ID: 477732
    [Abstract] [Full Text] [Related]

  • 5. Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain.
    Wong DT, Horng JS.
    Res Commun Chem Pathol Pharmacol; 1977 Apr 01; 16(4):749-52. PubMed ID: 193169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain.
    Rothman RB, Westfall TC.
    Mol Pharmacol; 1982 May 01; 21(3):538-47. PubMed ID: 7110115
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors.
    Smith JR, Simon EJ.
    Proc Natl Acad Sci U S A; 1980 Jan 01; 77(1):281-4. PubMed ID: 6244551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
    Pfeiffer A, Herz A.
    Eur J Pharmacol; 1982 Feb 05; 77(4):359-61. PubMed ID: 6277680
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.